Introduction to Bleeding Disorders
Lecture 1 of 2 — the physiology of hemostasis, then the patient who bleeds: four questions, hemophilia and ITP.
These slides are an outline only. Read the notes under each slide below with them, and chapters 20 to 25 of the Hematology Handbook. Then work through Case 53 in the Internal Medicine Casebook and the Hematology Question Bank. The next lecture is Disorders of Hemostasis.

Introduction to Bleeding Disorders
These slides are an outline only. Read the notes under each slide on this page with them, and chapters 20 to 25 of the Hematology Handbook. Then work through Case 53 in the Internal Medicine Casebook and the Hematology Question Bank. The next lecture is Disorders of Hemostasis.
Welcome. This lecture is about the patient who bleeds.
We will not learn the coagulation cascade for its own sake. We will learn it because each question we ask the patient needs a piece of it.
The plan: four questions, asked in the order a clinician meets them. Then two cases that run the same four questions: a boy with hemophilia and a young woman with immune thrombocytopenia (ITP). Then a short look at the adult who starts bleeding late in life.
The slides are an outline. The detail is in the handbook, chapters 20 to 25, and in Case 53 of the casebook. The next lecture, Disorders of Hemostasis, goes deeper into the history, the laboratory tests and von Willebrand disease.

Hemostasis: from injury to clot
Start with what normally happens when a vessel is cut.
1. Injury. The vessel breaks and blood leaks out. Straight away, the smooth muscle in the wall contracts. This narrows the vessel and slows the loss.
2. The platelet plug. Platelets stick to the exposed collagen at the break. They change shape and release signals that call in more platelets. Within seconds there is a soft plug. This is primary hemostasis.
3. The fibrin clot. At the same time, the clotting factors make thrombin, and thrombin turns fibrinogen into fibrin. Fibrin strands bind the plug and trap red cells. This is secondary hemostasis. Later, when the vessel heals, the clot is dissolved.
The rest of this first part explains each of these steps, and gives each one a test and a disease.
The illustration is from OpenStax Anatomy and Physiology, under a CC BY 3.0 licence, cropped from the original figure.
Image credit.
- 1909 Blood Clotting (OpenStax, Anatomy & Physiology) Wikimedia Commons · CC BY 3.0 · OpenStax

Hemostasis: a balance
Hemostasis is a balance. On one side, the things that form a clot: platelets, the clotting factors, and the injured vessel wall. On the other side, the things that prevent a clot: the natural anticoagulants, fibrinolysis, and the intact vessel wall.
Notice that the endothelium is on both sides. Intact endothelium keeps blood liquid. It makes prostacyclin and nitric oxide, carries heparan sulfate and thrombomodulin, and releases tissue plasminogen activator. Injured endothelium does the opposite. It exposes collagen and tissue factor, and releases von Willebrand factor.
A bleeding tendency means the balance has tipped toward prevention. Hemophilia is one example, not another word for bleeding. A low platelet count, von Willebrand disease and warfarin all tip it the same way, and they are not hemophilia.
A thrombosis tendency means it has tipped toward formation. That is the subject of handbook chapter 26.
ADAMTS13 is an enzyme that cuts large VWF strands. It works against thrombosis. When it is missing, the patient gets thrombotic thrombocytopenic purpura (TTP).

Four verbs: START, MAKE, STOP, CLEAN
Four verbs carry the whole subject: START, MAKE, STOP and CLEAN.
Notice that the list starts and ends with STOP. Blood at rest is kept liquid. The brakes are on all the time. Blood at rest is anticoagulant.
START is the platelet plug. It forms within seconds. We test it with the platelet count and the film. It fails in ITP, in von Willebrand disease and with aspirin.
MAKE is the fibrin clot that forms on the plug. We test it with the PT, the aPTT and the fibrinogen. It fails in hemophilia, with warfarin and in liver disease.
STOP again: the brakes keep the clot at the site of injury. Too little brake gives thrombosis, not bleeding.
CLEAN is fibrinolysis. Plasmin dissolves the clot once the vessel heals. The D-dimer is a product of this step. Too much fibrinolysis can itself cause bleeding.
Each verb has a test and a disease. Keep this line in mind for the rest of the lecture.

START: the platelet plug
START is the platelet plug. Think of three steps, and give each step its disease.
Step 1, adhesion. The injury exposes collagen. Von Willebrand factor (VWF) sticks to the collagen and catches platelets by their GPIb receptor. If VWF is low or faulty, that is von Willebrand disease. If GPIb is missing, that is Bernard-Soulier syndrome, where the platelets are large and the count is a little low.
Step 2, activation and release. The platelet changes shape and empties its granules. It makes thromboxane. These signals call in more platelets. Aspirin blocks the enzyme that makes thromboxane (cyclooxygenase). The block lasts for the life of the platelet, about 7 to 10 days. That is why aspirin is stopped well before surgery.
Step 3, aggregation. GPIIb/IIIa links one platelet to the next through fibrinogen. If GPIIb/IIIa is missing, that is Glanzmann thrombasthenia. The count and the platelet size are normal, but the platelets do not stick together. The patient bleeds badly.
A local point. On the Saudi registry for 2023, Glanzmann thrombasthenia is the largest of the rare bleeding disorders, with 356 patients. These are registry counts, not population prevalence. Glanzmann is recessive, so it is more common where marriage between relatives is common. The question on inherited or acquired bleeding comes back to this.
Note: injury exposes collagen and tissue factor. They are not released. Tissue factor starts coagulation (MAKE). It does not activate platelets. Thrombin and collagen do that.

MAKE: what the tests measure
This is the old cascade, drawn as a Y. It is still useful, but for one job only. It tells you what each test measures.
The PT starts with tissue factor and factor VII, then runs down the common path: X, V, II and fibrinogen. So a long PT points to VII or the common path.
The aPTT starts with XII, then XI, then IX with VIII, then the same common path. So a long aPTT with a normal PT points to XII, XI, IX or VIII.
Vitamin K is needed to make factors II, VII, IX and X, and the natural anticoagulants protein C and protein S. An old memory aid: "1972", read as 10, 9, 7, 2.
Warfarin blocks vitamin K, so it lowers all four factors, not only factor VII. Factor VII has the shortest life in the blood, so it falls first. That is why the PT (the INR) moves first and is used to monitor warfarin. Warfarin is not an "extrinsic pathway drug".
Remember the last line. The Y describes a test tube. It does not explain who bleeds in real life. For that we need the next slide.

Why hemophilia bleeds
Here is the puzzle. A boy with hemophilia has a normal factor VII and normal tissue factor. His "extrinsic pathway" works. His PT is normal. So why does he bleed so badly into his joints?
The answer is that clotting happens on cells, in three steps.
Step 1, the spark. On a cell carrying tissue factor, at the site of injury, tissue factor with factor VIIa activates factor X and factor IX. Xa with Va makes a little thrombin. This is not enough to make a good clot.
Step 2, amplify. That little thrombin activates platelets, and activates factors V, VIII and XI. (Not IX. IX is activated by TF-VIIa, and later by XIa.)
Step 3, the burst. On the surface of the activated platelet, IXa with VIIIa makes large amounts of Xa. Xa with Va then makes a burst of thrombin. Thrombin turns fibrinogen into fibrin, and factor XIIIa cross-links it into a firm clot.
Now hemophilia. Without factor VIII or IX, there is no IXa-VIIIa on the platelet, so there is no burst. The spark still happens, but the Xa made on the tissue-factor cell does not reach the platelet in useful amounts. It is made in the wrong place. The boy forms a weak clot that breaks down, so he bleeds late and keeps bleeding.
The second lesson is factor XII. In the test tube, the aPTT needs it, so XII deficiency gives a long aPTT. In the body, it plays no part in this model, and people with XII deficiency do not bleed. A long aPTT is not always a bleeding risk.
This model comes from Hoffman and Monroe, 2001.

STOP and CLEAN
STOP. Once a clot starts, the brakes keep it at the site of injury. There are three main brakes.
Tissue factor pathway inhibitor (TFPI) switches off the spark: TF-VIIa and Xa.
Antithrombin blocks thrombin and Xa.
Protein C is switched on when thrombin binds thrombomodulin on intact endothelium. Activated protein C, with protein S as its helper, cuts factors Va and VIIIa.
A lack of any of these brakes does not cause bleeding. It causes thrombosis. That is in handbook chapter 26.
CLEAN. When the vessel heals, the clot must go. Tissue plasminogen activator (tPA) turns plasminogen into plasmin. Plasmin cuts fibrin into fragments. Cross-linked fibrin gives a fragment called the D-dimer. There are brakes here too: PAI-1 blocks tPA, and thrombin bound to thrombomodulin switches on TAFI, which slows clot breakdown.
The D-dimer is sensitive but not specific. A raised D-dimer proves that cross-linked fibrin was broken down somewhere in the body. It does not tell you where or why. Surgery, infection, pregnancy, cancer and age all raise it. A normal D-dimer helps rule out a clot when the probability is low. A positive one does not rule a clot in.
Too much fibrinolysis is an uncommon cause of bleeding in its own right (handbook chapter 20).

The patient who bleeds
Now we use the physiology. Three people come to clinic. Each says the same thing: "I bleed."
Patient A is a 2-year-old boy. His knees swell and hurt, again and again. He bruised badly after a small fall.
Patient B is a 24-year-old woman. For three weeks she has had bruises and bleeding gums, and her last period was much heavier than usual. She had a viral illness a month ago.
Patient C is an older adult with sudden large bruises. He or she has had teeth out and surgery in the past without any trouble.
Ask the room to vote: which of these is born with the problem, and which has acquired it? Which has a problem with platelets, and which with the clotting factors? Do not give the answers yet. We come back to all three at the end of the lecture.
(The boy and the woman are the cases from the handbook, chapter 25, and Case 53 of the casebook.)

Four questions
This is the map for the clinical part of the lecture. You now have the physiology; each question uses a piece of it. A bleeding patient answers four questions, in order. Each question needs one piece of physiology.
Question 1: is this a bleeding disorder at all, or a local problem? The complaint answers it.
Question 2: which step failed, the platelet plug or the fibrin clot? The examination and the story answer it.
Question 3: was the patient born with it, or did they acquire it? Past bleeding challenges, the family, drugs and illness answer it.
Question 4: what does the first panel of blood tests say? The count, the film, the PT, the aPTT and the fibrinogen.
Two cases then run the same four questions: a boy with hemophilia and a young woman with ITP.
By the end, you should be able to:
1. Decide from the history whether there is a local lesion or a bleeding disorder.
2. Sort bleeding into plug failure and clot failure, and explain it with START, MAKE, STOP and CLEAN.
3. Use three history questions to separate inherited from acquired bleeding, and say why family and consanguinity matter here.
4. Read the first panel into one of five patterns.
5. Explain why hemophilia bleeds badly though the extrinsic pathway works, and why factor XII deficiency does not bleed.
6. Diagnose hemophilia and ITP from a story and first tests, and say what must be excluded before calling a low count ITP.
7. Name the acquired causes to think of first in an adult who bleeds, including those seen in this region.

Local bleed or bleeding disorder?
The first question is whether this is a bleeding disorder at all.
Bleeding from one site, on its own, is usually local. A nosebleed, blood in the urine, vomiting blood or coughing blood: look for the lesion first. A vessel, an ulcer, a tumour, a stone. Do not send a coagulation screen and forget the endoscopy.
A bleeding disorder usually shows a pattern. More than one site. Bleeding out of proportion to the injury. Bleeding after past challenges, like a tooth extraction, surgery, childbirth or circumcision. A family history.
One caution. A patient with a disorder can still present first with one site. So the rule tells you where to look first, not where to stop.
Disorders of Hemostasis, the next lecture, covers the full bleeding history and the ISTH bleeding assessment tool.

Plug or clot?
Now we can answer question 2: which step failed?
If the plug failed, the bleeding is in the skin and mucosa. Petechiae, bruises, bleeding gums, nosebleeds, heavy periods. It starts straight after the injury, because the plug is the first thing that should have stopped it. Think of a low platelet count, poor platelet function, or von Willebrand disease.
If the clot failed, the bleeding is deep: into joints and muscles. The plug forms, so the first bleeding stops. Then the plug is not reinforced by fibrin, and the bleeding starts again hours later. There are no petechiae. Think of hemophilia, other factor deficiencies, anticoagulants and liver disease.
One line to remember: petechiae are a platelet sign. People with hemophilia do not get petechiae.
The pattern narrows the diagnosis before any test is sent. (Handbook chapters 20 and 21.)

Inherited or acquired?
Question 3: was the patient born with it, or did they acquire it?
Past hemostatic challenges are natural tests. Circumcision, a tooth extraction, a tonsillectomy, surgery, childbirth, periods since menarche. A person who passed all of these without trouble, and now bleeds, has an acquired problem. A person who bled at each of them was probably born with it.
The family. Hemophilia is X-linked, so look at the brothers and the mother's brothers. Von Willebrand disease and most rare factor deficiencies are autosomal, so both sexes are affected. Ask whether the parents are related.
Drugs and illness. In adults, most bleeding is acquired. Antiplatelet drugs and anticoagulants are the commonest cause of all. Ask about anti-inflammatory drugs and herbal products too. Ask about liver disease, kidney failure, cancer, infection and pregnancy.
A local point. A national Saudi survey from 2004 to 2005 found that about 56% of marriages were between relatives (El-Mouzan and colleagues, 2007). That figure is national and old. We have no newer national figure, and no good figure for Asir. But the point stands: recessive disorders such as Glanzmann thrombasthenia and the rare factor deficiencies are not rare here, so ask every patient.
Simple rule: lifelong points to inherited. New in an adult points to acquired.

First-panel patterns
Question 4: what does the first panel say? The first panel is the platelet count, the blood film, the PT, the aPTT and the fibrinogen. Read it into one of five patterns.
1. Low platelets. Look at the film before anything else. Is the count real, or are the platelets clumped in the tube? Are there blasts or fragmented red cells? Then think of ITP, marrow disease, TTP, DIC and heparin-induced thrombocytopenia (HIT).
2. Long PT alone. Factor VII deficiency, early warfarin effect, early liver disease, vitamin K deficiency.
3. Long aPTT alone. Hemophilia A or B, factor XI or XII deficiency, von Willebrand disease (VWF carries factor VIII), heparin, or a lupus anticoagulant. The lupus anticoagulant is the odd one. It prolongs the aPTT in the tube but causes clots in the patient, not bleeding.
4. Both long. DIC, where the fibrinogen is low; severe liver disease; vitamin K deficiency; warfarin; massive transfusion.
5. All normal, but the patient clearly bleeds. Von Willebrand disease, a platelet function defect, factor XIII deficiency, or a cause in the vessel wall. A normal screen does not exclude a bleeding disorder. Hold on to that; the lecture ends with it.
If a clotting time is long and there is no obvious cause, the next step is a mixing test. Patient plasma is mixed with normal plasma. If the time corrects, a factor is missing. If it does not correct, something is blocking it: an inhibitor. How the test is done, and its traps, are in the next lecture, Disorders of Hemostasis.
(These patterns are from Case 53 and handbook chapter 21.)

Case 1
Case 1. A 2-year-old boy. His knees swell and hurt, again and again. He had a large bruise after a small fall. (Handbook chapter 25.)
Let the students run the questions aloud.
Question 1: is this a bleeding disorder? Yes. More than one bleed, at more than one site, out of proportion to the injury.
Question 2: which step failed? Bleeding into joints, with no petechiae, is deep bleeding. The clot failed: MAKE.
Question 3: born with it or acquired? A toddler with a pattern like this points to inherited. A boy points to an X-linked disorder. Ask about bleeding at circumcision, and about bleeding in his brothers and his mother's brothers. Ask whether the parents are related.
Question 4, the first panel, is on the next slide. Ask the room to predict it first: which test will be long?

Case 1: first panel
Here is his first panel. The platelet count is normal. The PT is normal. The aPTT is long. That is pattern 3: a long aPTT alone.
The next step is the mixing test. His plasma is mixed with normal plasma, and the aPTT corrects. So a factor is missing. Nothing is blocking it.
The specific factor assays then name the factor. Factor VIII is below 1%. This is severe hemophilia A.
Why below 1% means severe is on the next slide.
Note that the A and B forms look the same at the bedside. Only the factor assay tells them apart.

Hemophilia
Hemophilia in one slide.
Severity follows the factor level. Below 1% is severe: bleeding into joints and muscles with no injury at all. 1 to 5% is moderate: bleeding after minor injury. 5 to 40% is mild: bleeding mainly with surgery or major injury. A mild patient may not be found until the first operation. (Handbook chapter 25.)
It is X-linked recessive. Most patients are males. Women who carry the gene can bleed too, if their factor level is low. Do not dismiss a carrier who bleeds.
Hemophilia A, factor VIII, is far more common than hemophilia B, factor IX. They cannot be told apart at the bedside.
The hallmark is joint bleeding. Bleeds come back to the same joints, the target joints, and over years these joints are damaged. The bleeds to fear are inside the head and behind the abdomen (retroperitoneal).
Treatment, in one line: replace the missing factor. The details belong to hematology.
Two safety rules: no intramuscular injections, and no anti-inflammatory drugs. Both cause bleeding.
A local point. The Saudi registry for 2023 counts 1,595 people with hemophilia: 1,281 with A and 306 with B. These are registered patients, not population prevalence (World Federation of Hemophilia Global Survey 2023).

Case 2
Case 2. This is Case 53 in the casebook.
A 24-year-old woman. For three weeks she has bruised easily on her legs. Her gums bleed when she brushes her teeth. She has had two long nosebleeds, and her last period was far heavier than usual. She had a viral illness a month ago. She is otherwise well and takes no medicines.
On examination: petechiae over the shins and forearms, scattered bruises, and blood blisters inside the mouth. No enlarged lymph nodes, no enlarged liver or spleen, no bone tenderness. Fundoscopy is normal.
Let the students run the questions.
Question 1: a disorder? Yes. Many sites at the same time.
Question 2: which step? Skin and mucosa, with petechiae. The plug failed: START.
Question 3: born or acquired? Three weeks of new symptoms, with no bleeding history before. Acquired.
Question 4: the first panel. For a plug pattern, start with the platelet count and the film.
The blood blisters in the mouth are "wet purpura". Keep them in mind. They change the urgency.

Case 2: first panel and film
Her first panel. Platelets 8 ×10⁹/L. Hemoglobin 118 g/L. White cells normal, with a normal differential. PT and aPTT normal. This is pattern 1: low platelets, everything else close to normal.
Before you treat a low platelet count, look at the blood film. Always.
Her film shows few platelets, some of them large. There are no clumps, no blasts and no fragmented red cells.
The film could have shown other things, and each would change the problem.
Clumps. The platelets have stuck together in the tube, and the machine counts a clump as one cell. The count is false. This is not a disease. Repeat the count in a different anticoagulant.
Fragmented red cells (schistocytes). Something is shearing the red cells. Think of TTP or DIC. These are emergencies.
Blasts. This is marrow disease, such as acute leukemia. A different lecture, and a different urgency.
A low count has three causes: the marrow makes too few, the body destroys too many, or a large spleen holds them back.
The three images are from Wikimedia Commons, under the licences shown on the slide. They are the same images used in the investigations lecture.
Image credit.
- Platelet clumping (Platelet Clumping 8.jpg) Wikimedia Commons · CC BY-SA 4.0 · Erhabor Osaro
- Schistocytes (Schizocyte smear 2009-12-22.JPG) Wikimedia Commons · CC BY-SA 3.0 · Paulo Henrique Orlandi Mourão
- Blasts in acute myeloid leukemia (AML-M2 associated with a t(8;21) chromosome abnormality.jpg) Wikimedia Commons · public domain · Armed Forces Institute of Pathology

ITP: diagnosis
ITP, immune thrombocytopenia, is what is left once everything else is excluded. No test proves it.
Before you call it ITP, go through the list.
Clumping: her film shows none, so the count is real.
Marrow disease: she has no nodes, no big spleen, no bone pain, and her hemoglobin and white cells are near normal. Lymph nodes or a big spleen would argue against ITP and toward leukemia or lymphoma. Their absence is a real finding. If the whole count is low, the marrow needs a look; see the leukemia lecture.
TTP: no fragmented red cells on the film.
DIC: her PT and aPTT are normal.
HIT: she has had no heparin.
ITP can be primary, or secondary to another illness. So send HIV and hepatitis C serology, a test for H. pylori, ANA, immunoglobulins, thyroid tests and a pregnancy test.
A bone marrow test is not needed in a typical young patient. Do it when something does not fit: older age, fever or weight loss, other low counts, an abnormal film, or no response to treatment. (Case 53.)
Her blood blisters in the mouth are wet purpura. They mark a higher risk of serious bleeding. She needs treatment today. Retinal hemorrhage means the same.
Treatment is decided by the bleeding, not by the count, and it is managed by hematology.

Acquired hemophilia
This is patient C from the start: the older adult with sudden large bruises.
Acquired hemophilia is a different disease from hemophilia. The patient makes an autoantibody against their own factor VIII. It appears in a person who has never bled before, often an older adult or a woman after childbirth. It is not inherited, and it affects both sexes.
The bleeding is sudden and can be severe. The first panel shows a long aPTT alone, with a normal PT and platelet count. That is the same pattern as hemophilia. The history is what differs: this person passed all the past challenges.
The mixing trap. In the textbook, an inhibitor means the aPTT does not correct on mixing. But this antibody works slowly, and its effect depends on time and temperature. An immediate mix can look corrected. So the laboratory compares the aPTT straight after mixing and again after 2 hours at 37 °C. A mixing test alone cannot prove or exclude the diagnosis.
What to do: recognise it, and call hematology the same day.

Acquired causes in adults
In an adult who starts to bleed, think of the acquired causes first. They are far more common than the inherited ones.
Antiplatelet and anti-inflammatory drugs. The commonest cause of all. The count and the screen are normal, because the platelets are there but do not work.
Warfarin. It lowers all four vitamin K factors: II, VII, IX and X. The PT (INR) rises first.
Heparin. It prolongs the aPTT.
The direct oral anticoagulants have no routine monitoring test, so the drug history finds them, not the screen.
Liver disease. The PT rises first, then both. But the liver also makes less of the natural anticoagulants, so the balance is reset at a lower level, not simply tipped toward bleeding. The INR does not measure the bleeding risk in liver disease.
Vitamin K deficiency. Also a long PT, then both.
DIC. Always secondary: sepsis, cancer, an obstetric emergency, trauma. Both times are long, the fibrinogen is low, the D-dimer is high, the platelets fall, and there are fragments on the film. The answer is to find and treat the cause.
Kidney failure. Uremia makes platelets work poorly, with a normal count and screen.
(Case 53; handbook chapters 23, 25 and 27.)

Regional points
The history depends on where you practise. In this region, ask about three more things.
Snakebite. Some snake venoms cause a coagulopathy. In a patient who bleeds without a clear cause, ask about a bite. A study from four tertiary hospitals in Asir, 2000 to 2021, reports coagulopathy after snakebite (Alfaifi and colleagues, Eastern Mediterranean Health Journal 2024).
Alkhurma hemorrhagic fever, in Najran. A series of 28 cases from 2006 to 2009: nosebleeds in 8 patients, gum bleeding in 5, and no deaths (Alzahrani and colleagues, Emerging Infectious Diseases 2010).
Dengue, on the Red Sea coast. Jeddah and Makkah reported cases in 2013 (Aziz and colleagues, 2014). We found no regional figures for how often dengue patients bleed, including in Jazan.
The honest position: good Saudi data on bleeding disorders are few. Most come from Riyadh, Madinah and the Eastern Province. None of the numbers in this lecture is for Asir unless it says so. Use them as reasons to ask, not as local rates.

The three patients, and a fourth
Back to the three patients.
Patient A, the boy: deep, delayed bleeding into joints; a long aPTT alone that corrects on mixing; factor VIII below 1%. Severe hemophilia A. Inherited, and a failure of MAKE.
Patient B, the young woman: new bleeding in skin and mucosa; platelets 8; a clean film; everything else excluded. ITP. Acquired, and a failure of START.
Patient C, the older adult: new, severe bleeding in someone who never bled before; a long aPTT alone. Think of acquired hemophilia, and call hematology. Check the drug list first, because drugs are the commonest acquired cause.
Now a fourth patient. A 19-year-old woman. Heavy periods since her teens, easy bruising, and long bleeding after her wisdom teeth were removed. Her platelet count, PT and aPTT are all normal. (Handbook chapter 21.)
Ask the room: does the normal screen mean she has no bleeding disorder? No. A lifelong history of skin and mucosal bleeding with a normal screen is the classic picture of the most common inherited bleeding disorder. The screen misses it. It also misses mild factor deficiencies, platelet function defects and factor XIII deficiency.
What is it, and how do we prove it? That is where the next lecture, Disorders of Hemostasis, begins.
Ask every woman with heavy periods whether they have been heavy since her first period.

Read next
Tonight: read handbook chapters 20 to 25. Read Case 53 in the casebook, which finishes Case 2. Try the hematology question bank items 46 to 59.
The next lecture, Disorders of Hemostasis, picks up patient D. It covers the full bleeding history and the bleeding score, the PT, aPTT and mixing test in depth, and patient D's diagnosis.
Image credits are on the slide.
Image credits. All other figures were drawn for this lecture.
- Slide 2: 1909 Blood Clotting (OpenStax, Anatomy & Physiology) by OpenStax, via Wikimedia Commons, CC BY 3.0 (cropped; leader lines removed from the fibrin-clot panel).
- Slide 19: Platelet clumping (Platelet Clumping 8.jpg) by Erhabor Osaro, via Wikimedia Commons, CC BY-SA 4.0.
- Slide 19: Schistocytes (Schizocyte smear 2009-12-22.JPG) by Paulo Henrique Orlandi Mourão, via Wikimedia Commons, CC BY-SA 3.0.
- Slide 19: Blasts in acute myeloid leukemia (AML-M2 associated with a t(8;21) chromosome abnormality.jpg) by Armed Forces Institute of Pathology, via Wikimedia Commons, public domain.